News | July 04, 2006

FDA’s Deadline Nears for all Prescription, Over-the-Counter Medication Bar Code Labeling

Bar coding for all prescription and over-the-counter medications — which are commonly used and dispensed in the acute-care setting — will be required as of April 26, marking the end of a two-year implementation period for the FDA’s 2004 rule. Medications that are FDA cleared on or after April 26 must be bar code labeled within 60 days of their approval date.
Drug manufacturers, repackers, relabelers and private label distributors will be responsible for affixing human- and machine-readable bar code labels on all unit-dose medications, encoding the National Drug Code (NDC) on both the medication’s packaging as well as any overwrap.
The FDA has estimated that the rule will prevent more than 500,000 medication errors and save more than $93 billion in healthcare costs over the next 20 years.
The rule applies to most drug products, as well as blood and biological products, and bar codes must conform to EAN (European Article Numbering), UCC (Uniform Code Council) or HIBCC (Health Industry Business Communications Council) format standards.
Products that are exempt from the bar code rule include section 510 animal drugs, as well as prescription drug samples, allergenic extracts, intrauterine contraceptive devices regulated as drugs, medical gases, radiopharmaceuticals, low density polyethylene form fill and seal containers that are not packaged with an overwrap and prescription drugs sold directly to patients. Also exempted are Section 510 (g) hospital compounded drugs and drugs used in clinical trials.

Related Content

ScImage Awarded U.S. Government DIN-PACS IV Contract
News | PACS | August 16, 2017
ScImage Inc. was recently awarded a new DIN-PACS IV (Digital Imaging Network/Picture Archiving and Communications...
Neighbors Emergency Center Selects Novarad PACS/RIS
News | PACS | August 15, 2017
August 15, 2017 — Novarad Corp.
Fujifilm Launches Synapse PACS Version 5
Technology | PACS | August 03, 2017
August 3, 2017 – Fujifilm Medical Systems U.S.A. Inc.
RamSoft has teamed up with Availity to bring healthcare providers Patient Access and Patient Authorizations
News | PACS | July 31, 2017
RamSoft has teamed up with Availity to bring healthcare providers Patient Access and Patient Authorizations, two fully...
Agfa Receives FDA 510(k) for Xtend Functionalities on Xero Universal Viewer
Technology | Remote Viewing Systems | July 27, 2017
Agfa HealthCare announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Xero Xtend...
Philips Receives FDA 510(k) Clearance for IntelliSpace Portal 9.0
Technology | Advanced Visualization | June 29, 2017
Philips announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market...
Envision Diagnostic Center Deploys Exa PACS Across 11 Facilities
News | Enterprise Imaging | June 28, 2017
Envision Diagnostic Center (Novi, Mich.) has implemented Exa PACS (picture archiving and communication system) from...
Fujifilm's Synapse PACS Granted Authority to Operate Under New U.S. DoD Process
News | PACS | June 26, 2017
June 26, 2017 — Fujifilm Medical Systems U.S.A. Inc.
News | PACS | June 23, 2017
Medidata and Median Technologies announced a new collaboration to streamline the growth and use of medical imaging in...
RamSoft Partners With Gamel to Enhance Patient Care in Peruvian Market
News | PACS | June 23, 2017
RamSoft announced a new partnership with Peru-based medical imaging equipment provider, Gamel. With RamSoft’s...
Overlay Init